AID-deficient CLL cells stimulated with LPS had higher levels of phospho-SYK as measured by flow cytometry (Fig. 2E) and were also more sensitive to treatment with a BTK inhibitor ibrutinib (Fig. 2F). This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.